A Call to Action: Insights into Hypertension Prevalence and Management in an Urban Sub-Saharan African Population
Main Article Content
Keywords
Urban Health, Sub-Saharan Africa, Public Health, Healthcare Access, Lifestyle Factors, Cameroon, Hypertension
Abstract
Background: Hypertension is a global health challenge, with a disproportionate burden in low- and middle-income countries like Cameroon. Urban centers, such as Yaoundé, face increasing prevalence driven by rapid urbanization and healthcare disparities. The study objective is to assess hypertension prevalence, associated risk factors, and barriers to effective management in an urban Cameroonian population.
Methodology: A cross-sectional study was conducted in 2024 as part of the HEAVEN-CIEL Hypertension Awareness Campaign. Data from 181 adults were collected through structured questionnaires and physical assessments, including blood pressure measurements. Associations with demographic, socioeconomic, and lifestyle factors were analyzed using chi-square tests and logistic regression.
Results: Hypertension prevalence was 59.67%, with rates peaking at 75.56% among individuals aged 46–60 years (p = 0.0019). Medium-income participants showed the highest prevalence at 75.56% (p = 0.043). Obesity (p = 0.0024) and high-fat diets (p = 0.0212) were significant risk factors. Alarmingly, 87.04% of hypertensive individuals were untreated, highlighting gaps in medication access and adherence.
Conclusion: Hypertension in Yaoundé represents a major public health concern, driven by age, socioeconomic disparities, and unhealthy lifestyle factors. The low treatment rates reflect systemic healthcare barriers. Comprehensive, culturally sensitive interventions are urgently needed to improve awareness, prevention, and management. Future research should focus on the longitudinal impacts of targeted public health strategies.
References
2. Jeemon P, Séverin T, Amodeo C, et al. World Heart Federation roadmap for hypertension – A 2021 update. Glob Heart. 2021;16(1):e1-e10.
3. Campbell NR, Whelton PK, Orias M, et al. 2022 World hypertension league, resolve to save lives and international society of hypertension dietary sodium (salt) global call to action. Journal of Human Hypertension 2023;37(6):428-437.
4. Schutte AE, Srinivasapura Venkateshmurthy N, Mohan S, Prabhakaran D. Hypertension in low-and middle-income countries. Circulation research 2021;128(7):808-826.
5. Rojas Rueda D. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA, 2017, vol 317, num 2, p 165-182 2017.
6. Dzudie A, Kengne AP, Muna WF, et al. Prevalence, awareness, treatment, and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ Open 2012;2(4) (In eng). DOI: 10.1136/bmjopen-2012-001217.
7. Chiavarini M, Dolcini J, Firmani G, Ponzio E, Barbadoro P. Prevalence of Diabetes, Hypertension, and Associated of Cardiovascular Diseases: A Comparative Pre- and Post-COVID Study. Diseases 2024;12(12) (In eng). DOI: 10.3390/diseases12120329.
8. Elendu C, Amaechi DC, Elendu TC, Amaechi EC, Elendu ID. Dependable approaches to hypertension management: A review. Medicine (Baltimore) 2024;103(24):e38560. (In eng). DOI: 10.1097/md.0000000000038560.
9. Gafane-Matemane LF, Craig A, Kruger R, et al. Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities. J Hum Hypertens 2024 (In eng). DOI: 10.1038/s41371-024-00913-6.
10. Itua MO. Impact of culturally appropriate hypertension education with remote patient monitoring on adherence to antihypertensive medication among US African immigrants. D'Youville College; 2024.
11. Abariga SA, Al Kibria GM, Albrecht JS. Impact of the 2017 American College of Cardiology/American Heart Association Guidelines on Prevalence of Hypertension in Ghana. Am J Trop Med Hyg 2020;102(6):1425-1431. (In eng). DOI: 10.4269/ajtmh.19-0272.
12. Al Kibria GM, Nemirovsky A, Sharmeen A, Day B. Age-stratified prevalence, treatment status, and associated factors of hypertension among US adults following application of the 2017 ACC/AHA guideline. Hypertens Res 2019;42(10):1631-1643. (In eng). DOI: 10.1038/s41440-019-0275-x.
13. Hernández-Vásquez A, Rojas-Roque C, Santero M, Ruiz-Maza JC, Casas-Bendezú M, Miranda JJ. [Changes in the prevalence of hypertension in Peru using the new guideline of the American College of Cardiology]. Rev Med Chil 2019;147(5):545-556. (In spa). DOI: 10.4067/s0034-98872019000500545.
14. Zhou Y, Jia L, Lu B, et al. Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline. J Clin Hypertens (Greenwich) 2019;21(6):758-765. (In eng). DOI: 10.1111/jch.13564.
15. Bazo-Alvarez JC, Del Castillo D, Piza L, et al. Multimorbidity patterns, sociodemographic characteristics, and mortality: Data science insights from low-resource settings. Am J Epidemiol 2024 (In eng). DOI: 10.1093/aje/kwae466.
16. Daskalopoulou SS, Papacostas-Quintanilla H, Brzozowska-Villatte R. Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice. Adv Ther 2024 (In eng). DOI: 10.1007/s12325-024-03091-6.
17. Katundu KGH, Mukhula V, Matemvu Z, et al. Barriers and facilitators to integration of screening for hypertension, diabetes mellitus, and dyslipidaemia, among adult people living with HIV at district hospital ART clinics in Southern Malawi. Res Sq 2024 (In eng). DOI: 10.21203/rs.3.rs-5373585/v1.
18. Liu L, Li C, Cai J, et al. Trends and levels of the global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021: findings from the global burden of disease study 2021. Front Med (Lausanne) 2024;11:1515961. (In eng). DOI: 10.3389/fmed.2024.1515961.
19. Rashid A, Ejara D, Deybasso HA. Adherence to antihypertensive medications and associated factors in patients with hypertension, Oromia, Ethiopia: a multicenter study. Sci Rep 2024;14(1):30712. (In eng). DOI: 10.1038/s41598-024-80086-x.
20. Rezaianzadeh A, Johari MG, Baeradeh N, Seif M, Hosseini SV. Sex differences in hypertension incidence and risk factors: a population-based cohort study in Southern Iran. BMC Public Health 2024;24(1):3575. (In eng). DOI: 10.1186/s12889-024-21082-8.
21. Schwarz M, Gyawali B, Nkonge-Ngumba DM, Anekha SK, Ngure M, Dræbel TA. A cross-sectional study on socio-demographic correlates of self-reported self-care practices for hypertension and type 2 diabetes among adults living in rural Kenya. BMC Health Serv Res 2024;24(1):1624. (In eng). DOI: 10.1186/s12913-024-12088-4.
22. Zhu W, He X, Huang D, et al. Global and Regional Burden of Ischemic Stroke Disease from 1990 to 2021: An Age-Period-Cohort Analysis. Transl Stroke Res 2024 (In eng). DOI: 10.1007/s12975-024-01319-9.
23. Zhu Y, Wu S, Qiu W, Wang J, Feng Y, Chen C. Social Determinants of Health, Blood Pressure Classification, and Incident Stroke Among Chinese Adults. JAMA Netw Open 2024;7(12):e2451844. (In eng). DOI: 10.1001/jamanetworkopen.2024.51844.
24. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nature Reviews Cardiology. 2021 Nov;18(11):785-802.
25. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health 2024;9(10):e729-e744. (In eng). DOI: 10.1016/s2468-2667(24)00166-x.
26. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024;23(10):973-1003. (In eng). DOI: 10.1016/s1474-4422(24)00369-7.
27. Caturano A, Galiero R, Rocco M, et al. The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease. Biomolecules 2024;14(11) (In eng). DOI: 10.3390/biom14111393.
28. Chertow GM, Correa-Rotter R, Eckardt KU, et al. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. EClinicalMedicine 2024;72:102614. (In eng). DOI: 10.1016/j.eclinm.2024.102614.
29. Merwass NA, Alkhader YK, Alharthi SA, et al. The Role of Screening, Risk Factors, and Early Intervention in Preventing Diabetes in the Obese Population: A Systematic Review. Cureus 2024;16(7):e63952. (In eng). DOI: 10.7759/cureus.63952.
30. Müller SA, Elimian K, Rafamatanantsoa JF, et al. The burden and treatment of non-communicable diseases among healthcare workers in sub-Saharan Africa: a multi-country cross-sectional study. Front Public Health 2024;12:1375221. (In eng). DOI: 10.3389/fpubh.2024.1375221.
31. Ojo AE, Ojji DB, Grobbee DE, Huffman MD, Peters SAE. The Burden of Cardiovascular Disease Attributable to Hypertension in Nigeria: A Modelling Study Using Summary-Level Data. Glob Heart 2024;19(1):50. (In eng). DOI: 10.5334/gh.1332.
32. Silva S, Csőke E, Ng C, et al. Impact of socioeconomic determinants on outcomes of eight select conditions for which self-care is a modality for prevention and treatment: a scoping review. Curr Med Res Opin 2024;40(11):1921-1933. (In eng). DOI: 10.1080/03007995.2024.2417752.
33. Xu K, Evans D, Carrin G, Aguilar-Rivera AM. Designing health financing systems to reduce catastrophic health expenditure. 2005.
34. Ataguba JE-O, Goudge J. The impact of health insurance on health-care utilisation and out-of-pocket payments in South Africa. The Geneva Papers on Risk and Insurance-Issues and Practice 2012;37:633-654.
35. Wirtz VJ, Hogerzeil HV, Gray AL, et al. Essential medicines for universal health coverage. The Lancet 2017;389(10067):403-476.
36. Gafane-Matemane LF, Craig A, Kruger R, et al. Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities. Journal of Human Hypertension 2024:1-16.
37. Hendriks ME, Wit FW, Roos MT, et al. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PloS one 2012;7(3):e32638.
38. Ketor CE, McDonnell J, Benneh CK, et al. Determinants of health-seeking behaviour in rural district of Jasikan, Ghana: a cross-sectional study. BMC Public Health 2024;24(1):2972.
39. Dhar L, Earnest J, Ali M. A systematic review of factors influencing medication adherence to hypertension treatment in developing countries. Open Journal of Epidemiology 2017;7(03):211-250.
40. Ojo AE, Ojji DB, Grobbee DE, Huffman MD, Peters SA. The Burden of Cardiovascular Disease Attributable to Hypertension in Nigeria: A Modelling Study Using Summary-Level Data. Global Heart 2024;19(1).
41. Dzudie A, Kengne AP, Muna WF, et al. Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ open 2012;2(4):e001217.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.
Teko Blaise Mbah, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Bernadette Sandrine Lema, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Armand Boris Rikam, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Jacques Merci Baning Baning, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Serges Bruno Ngon, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Georgette Merveille Kilama, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Divine GoufanA Ngon, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Odile Israelle Meto A Ngon, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Fabrice Peguy Thome Ebango, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Suzanne Adolphine Soppi Ebango, Heaven Foundation/Foundation CIEL Hartford, Connecticut, USA
Harmony Health Physical and Spiritual Wellness Center (Harmony Care), Woodland Medical Centre, Hartford, Connecticut, USA
Emmanuel Eroume A Egom, Hartford HealthCare Heart and Vascular Institute, Southington, Connecticut, USA
Institut du Savoir Montfort (ISM), Ottawa, Canada
Laboratory of Human Metabolism and Non-Communicable Diseases, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé, Cameroon